
|Slideshows|April 17, 2019
Highs and Lows in New Bipolar Research
Author(s)Leo Robert
Recent study results offer some good news and some bad. A concise summary of key findings here.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Postmodern Worldview and Contemporary Psychiatry
2
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
3
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
4
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
5









